OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
26
Results
Show all
Save search
Copy query
Show results for
Unknown
(26)
Publication Date
Release Date
2021
(4)
2025
(3)
2024
(3)
2023
(3)
2018
(3)
2022
(2)
2019
(1)
2017
(1)
2016
(1)
2015
(1)
2014
(1)
2012
(1)
2011
(1)
2009
(1)
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
Characteristics of the Western Province, Zambia, trial site for evaluation of attractive targeted sugar baits for malaria vector control.
Not available
S-EPMC11102358
|
biostudies-literature
Cite
Inosine to increase serum and cerebrospinal fluid urate in Parkinson disease: a randomized clinical trial.
Not available
S-EPMC3940333
|
biostudies-literature
Cite
Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial.
Not available
S-EPMC5594247
|
biostudies-literature
Cite
Neutralizing Antibody Immune Correlates for a Recombinant Protein Vaccine in the COVAIL Trial.
Not available
S-EPMC11797383
|
biostudies-literature
Cite
Gene and pathway level analyses of germline DNA-repair gene variants and prostate cancer susceptibility using the iCOGS-genotyping array.
Not available
S-EPMC5379914
|
biostudies-literature
Cite
Multiple novel prostate cancer susceptibility signals identified by fine-mapping of known risk loci among Europeans.
Not available
S-EPMC4572072
|
biostudies-literature
Cite
Letrozole therapy alone or in sequence with tamoxifen in women with breast cancer.
Not available
S-EPMC2921823
|
biostudies-literature
Cite
The advantage of letrozole over tamoxifen in the BIG 1-98 trial is consistent in younger postmenopausal women and in those with chemotherapy-induced menopause.
Not available
S-EPMC4802157
|
biostudies-literature
Cite
Prediction of disability-free survival in healthy older people.
Not available
S-EPMC9213595
|
biostudies-literature
Cite
Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8·1 years median follow-up.
Not available
S-EPMC3235950
|
biostudies-literature
Cite
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets